Skip to main content
VCbacked
Log inGet Started

Foghorn Therapeutics

Cambridge, United States

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

$50.0M raised
Jan 2026
Post-IPO Equity
BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

Top Investors

Casdin CapitalInvusDeerfield ManagementFlagship PioneeringIrving Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Foghorn Therapeutics

How much funding has Foghorn Therapeutics raised?
Foghorn Therapeutics has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.
Who are Foghorn Therapeutics's investors?
Foghorn Therapeutics's investors include Casdin Capital, Invus, Deerfield Management, Flagship Pioneering, Irving Investors.
Where is Foghorn Therapeutics headquartered?
Foghorn Therapeutics is headquartered in Cambridge, United States.
What does Foghorn Therapeutics do?
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
What stage is Foghorn Therapeutics at?
Foghorn Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Foghorn Therapeutics — Funding & Investors." VCBacked, January 9, 2026, https://www.vcbacked.co/company/foghorn-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Foghorn Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/foghorn-therapeutics
Wikipedia (cite web)
{{cite web |title=Foghorn Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/foghorn-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M